These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15240845)

  • 1. Immunosuppression and modulation in liver transplantation.
    Encke J; Uhl W; Stremmel W; Sauer P
    Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv22-5. PubMed ID: 15240845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.
    Chang GJ; Mahanty HD; Quan D; Freise CE; Ascher NL; Roberts JP; Stock PG; Hirose R
    Liver Transpl; 2000 Nov; 6(6):734-40. PubMed ID: 11084060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive treatment].
    Niaudet P
    Nephrol Ther; 2011 Dec; 7(7):592-8. PubMed ID: 22118788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of chronic rejection after treatment failure with FK506 and RS61443.
    Roberts JP; Lake JR; Hebert M; Nikolai B; Ascher NL; Ferrell LD
    Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient.
    Iglesias J; Ortega J; López JA; Sánchez L; Allende E; Asensio M; Margarit C
    Transpl Int; 2003 Oct; 16(10):765-7. PubMed ID: 12827229
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
    Eason JD; Nair S; Cohen AJ; Blazek JL; Loss GE
    Transplantation; 2003 Apr; 75(8):1396-9. PubMed ID: 12717237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression: towards a logical approach in liver transplantation.
    Perry I; Neuberger J
    Clin Exp Immunol; 2005 Jan; 139(1):2-10. PubMed ID: 15606606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of immunosuppressive therapy on recurrence of hepatitis C.
    Everson GT
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S19-27. PubMed ID: 12362294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot-topic debate on hepatitis C virus: the type of immunosuppression matters.
    Trotter JF
    Liver Transpl; 2011 Nov; 17 Suppl 3():S20-3. PubMed ID: 21850693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
    Smith JM; Nemeth TL; McDonald RA
    Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the immunosuppressive regimen in heart transplantation.
    Eisen H; Ross H
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Skibba A; Kam I
    Liver Transpl; 2008 May; 14(5):633-8. PubMed ID: 18324656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.
    Samonakis DN; Triantos CK; Thalheimer U; Quaglia A; Leandro G; Teixeira R; Papatheodoridis GV; Sabin CA; Rolando N; Davies S; Dhillon AP; Griffiths P; Emery V; Patch DW; Davidson BR; Rolles K; Burroughs AK
    Liver Transpl; 2005 Apr; 11(4):386-95. PubMed ID: 15776454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
    Freise CE; Hebert M; Osorio RW; Nikolai B; Lake JR; Kauffman RS; Ascher NL; Roberts JP
    Transplant Proc; 1993 Apr; 25(2):1758-9. PubMed ID: 8470155
    [No Abstract]   [Full Text] [Related]  

  • 17. A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C.
    Rayhill SC; Barbeito R; Katz D; Voigt M; Labrecque D; Kirby P; Miller R; Stolpen A; Wu Y; Schmidt W
    Transplant Proc; 2006 Dec; 38(10):3625-8. PubMed ID: 17175350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
    Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should the immunosuppressive regimen be managed in patients with established chronic allograft failure?
    Danovitch GM
    Kidney Int Suppl; 2002 May; (80):68-72. PubMed ID: 11982816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.